Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant XELOX for Colorectal Cancer with Resectable Liver Metastasis
NCT00630045Phase 3Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2008
- Primary completion
- Jun 2010
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, capecitabine in colorectal cancer (CRC), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
oxaliplatincapecitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00630045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630045.